2 fantastic ASX growth shares to buy this month

ResMed Inc. (ASX:RMD) and this ASX growth share could be ones to buy in January. Here's why they are rated highly…

| More on:
A young boy sits on his dad's shoulders while both flex their muscles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Are you looking to add a growth share or two to your portfolio this month? Then take a look at the two ASX shares listed below.

Here's why they could be growth shares to buy right now:

Kogan.com Ltd (ASX: KGN)

The first growth share to look at is this ecommerce company. It has been a very strong performer over the last 12 months thanks to the accelerating shift to online shopping. With shops shutting at the height of the pandemic and people being locked down, millions of consumers went online for their shopping. This gave Kogan's performance a major boost, leading to explosive growth in FY 2020.

Pleasingly, although life is getting back to normal, consumers are still flocking online for shopping. This has led to Kogan's strong growth continuing in FY 2021. For example, during the first four months of FY 2021, Kogan's sales were up 99.8% and its operating earnings were up 268.8% over the same period last year.

In addition to this, the company has acquired online retailer Mighty Ape for NZ$120 million and furniture retailer Matt Blatt for $4.4 million. These additions look set to give its second half performance a boost.

Canaccord Genuity is a fan of Kogan and has a buy rating and $25.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another growth share to look at is ResMed. Its is a medical device company with a focus on the fast-growing sleep treatment market.

ResMed also manufactures ventilators, which have been in high demand during the pandemic. In fact, demand has been so strong, it offset softness in the sleep treatment side of the business and underpinned a very strong result in FY 2020 and stellar growth in the first quarter of the new financial year.

While COVID is likely to stifle the growth of the sleep treatment business in the near term, as fewer people are diagnosed with sleep apnoea, it has been tipped to accelerate its growth once trading conditions improve.

Analysts at Morgans are positive on the company. This week the broker retained its add rating and $30.99 price target on ResMed's shares. While it acknowledges that it could be facing some headwinds, it believes its future remains bright thanks to its new product pipeline and growing digital business.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Happy man working on his laptop.
Growth Shares

EOFY 2025: 3 ASX 200 shares to buy for the year ahead

Looking for quality picks for the next financial year? Here are three quality picks that analysts rate as buys.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Growth Shares

Macquarie tips nearly 50% upside for this ASX 200 stock

Let's see which stock the broker is feeling bullish about this week.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Growth Shares

3 excellent ASX 200 growth shares brokers rate as buys

Let's see why they think investors should be snapping them up right now.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

Why I think these 2 ASX shares are ideal for growth investors

These investments are very compelling.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Analysts really like these stocks. Here’s why…

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

5 ASX growth shares to buy and hold

Analysts think these shares could be top picks for investors looking for growth options.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

The ultimate buy and hold ASX 200 shares for long-term investors

These buy-rated shares could be great options for investors with a long time horizon.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

Read more »